PARP1 and Sepsis: To support the emerging concept of repositioning clinically used PARP inhibitors for the experimental therapy of septic shock, further data are required on the preclinical efficacy and safety of PARP1 inhibitors in experimental conditions that mimic sepsis or septic shock.